Coverage Decisions for Expensive Hemophilia Treatments
Russell P. Gollard, MD, FACP, discusses coverage decisions for expensive treatments in hemophilia, including total cost of care, drug availability, and real-world evidence.
Russellp Gollard Coverage Decisions Nexpensive Treatments Hemophilia Patients Total Cost Of Care Real World Evidence
Source: ajmc.com